Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Antibiotic Resistance Market Growth 2022-2028

  • LP 4915527
  • 105 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Antibiotic Resistance will have significant change from previous year. According to our (LP Information) latest study, the global Antibiotic Resistance market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Antibiotic Resistance market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Antibiotic Resistance market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antibiotic Resistance market, reaching US$ million by the year 2028. As for the Europe Antibiotic Resistance landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Antibiotic Resistance players cover Allergan, AmpliPhi Biosciences, BioVersys GmbH, and Macrolide Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Antibiotic Resistance market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

By Disease

By Pathogen

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Oxazolidinones

Lipoglycopeptides

Tetracyclines

Cephalosporins

Combination therapies

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Allergan

AmpliPhi Biosciences

BioVersys GmbH

Macrolide Pharmaceuticals

Melinta Therapeutics

Merck

Nabriva Therapeutics

Nemesis Bioscience

Phage Technologies S.A

Tetraphase Pharmaceuticals

The Medicines Company

TPfizer

Westway Health

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Antibiotic Resistance Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Antibiotic Resistance by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Antibiotic Resistance by Country/Region, 2017, 2022 & 2028

2.2 Antibiotic Resistance Segment by Type

2.2.1 Type I

2.2.2 Type II

2.3 Antibiotic Resistance Sales by Type

2.3.1 Global Antibiotic Resistance Sales Market Share by Type (2017-2022)

2.3.2 Global Antibiotic Resistance Revenue and Market Share by Type (2017-2022)

2.3.3 Global Antibiotic Resistance Sale Price by Type (2017-2022)

2.4 Antibiotic Resistance Segment by Application

2.4.1 Oxazolidinones

2.4.2 Lipoglycopeptides

2.4.3 Tetracyclines

2.4.4 Cephalosporins

2.4.5 Combination therapies

2.4.6 Other

2.5 Antibiotic Resistance Sales by Application

2.5.1 Global Antibiotic Resistance Sale Market Share by Application (2017-2022)

2.5.2 Global Antibiotic Resistance Revenue and Market Share by Application (2017-2022)

2.5.3 Global Antibiotic Resistance Sale Price by Application (2017-2022)

3 Global Antibiotic Resistance by Company

3.1 Global Antibiotic Resistance Breakdown Data by Company

3.1.1 Global Antibiotic Resistance Annual Sales by Company (2020-2022)

3.1.2 Global Antibiotic Resistance Sales Market Share by Company (2020-2022)

3.2 Global Antibiotic Resistance Annual Revenue by Company (2020-2022)

3.2.1 Global Antibiotic Resistance Revenue by Company (2020-2022)

3.2.2 Global Antibiotic Resistance Revenue Market Share by Company (2020-2022)

3.3 Global Antibiotic Resistance Sale Price by Company

3.4 Key Manufacturers Antibiotic Resistance Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Antibiotic Resistance Product Location Distribution

3.4.2 Players Antibiotic Resistance Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Antibiotic Resistance by Geographic Region

4.1 World Historic Antibiotic Resistance Market Size by Geographic Region (2017-2022)

4.1.1 Global Antibiotic Resistance Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Antibiotic Resistance Annual Revenue by Geographic Region

4.2 World Historic Antibiotic Resistance Market Size by Country/Region (2017-2022)

4.2.1 Global Antibiotic Resistance Annual Sales by Country/Region (2017-2022)

4.2.2 Global Antibiotic Resistance Annual Revenue by Country/Region

4.3 Americas Antibiotic Resistance Sales Growth

4.4 APAC Antibiotic Resistance Sales Growth

4.5 Europe Antibiotic Resistance Sales Growth

4.6 Middle East & Africa Antibiotic Resistance Sales Growth

5 Americas

5.1 Americas Antibiotic Resistance Sales by Country

5.1.1 Americas Antibiotic Resistance Sales by Country (2017-2022)

5.1.2 Americas Antibiotic Resistance Revenue by Country (2017-2022)

5.2 Americas Antibiotic Resistance Sales by Type

5.3 Americas Antibiotic Resistance Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Antibiotic Resistance Sales by Region

6.1.1 APAC Antibiotic Resistance Sales by Region (2017-2022)

6.1.2 APAC Antibiotic Resistance Revenue by Region (2017-2022)

6.2 APAC Antibiotic Resistance Sales by Type

6.3 APAC Antibiotic Resistance Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Antibiotic Resistance by Country

7.1.1 Europe Antibiotic Resistance Sales by Country (2017-2022)

7.1.2 Europe Antibiotic Resistance Revenue by Country (2017-2022)

7.2 Europe Antibiotic Resistance Sales by Type

7.3 Europe Antibiotic Resistance Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Antibiotic Resistance by Country

8.1.1 Middle East & Africa Antibiotic Resistance Sales by Country (2017-2022)

8.1.2 Middle East & Africa Antibiotic Resistance Revenue by Country (2017-2022)

8.2 Middle East & Africa Antibiotic Resistance Sales by Type

8.3 Middle East & Africa Antibiotic Resistance Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Antibiotic Resistance

10.3 Manufacturing Process Analysis of Antibiotic Resistance

10.4 Industry Chain Structure of Antibiotic Resistance

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Antibiotic Resistance Distributors

11.3 Antibiotic Resistance Customer

12 World Forecast Review for Antibiotic Resistance by Geographic Region

12.1 Global Antibiotic Resistance Market Size Forecast by Region

12.1.1 Global Antibiotic Resistance Forecast by Region (2023-2028)

12.1.2 Global Antibiotic Resistance Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Antibiotic Resistance Forecast by Type

12.7 Global Antibiotic Resistance Forecast by Application

13 Key Players Analysis

13.1 Allergan

13.1.1 Allergan Company Information

13.1.2 Allergan Antibiotic Resistance Product Offered

13.1.3 Allergan Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Allergan Main Business Overview

13.1.5 Allergan Latest Developments

13.2 AmpliPhi Biosciences

13.2.1 AmpliPhi Biosciences Company Information

13.2.2 AmpliPhi Biosciences Antibiotic Resistance Product Offered

13.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AmpliPhi Biosciences Main Business Overview

13.2.5 AmpliPhi Biosciences Latest Developments

13.3 BioVersys GmbH

13.3.1 BioVersys GmbH Company Information

13.3.2 BioVersys GmbH Antibiotic Resistance Product Offered

13.3.3 BioVersys GmbH Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 BioVersys GmbH Main Business Overview

13.3.5 BioVersys GmbH Latest Developments

13.4 Macrolide Pharmaceuticals

13.4.1 Macrolide Pharmaceuticals Company Information

13.4.2 Macrolide Pharmaceuticals Antibiotic Resistance Product Offered

13.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Macrolide Pharmaceuticals Main Business Overview

13.4.5 Macrolide Pharmaceuticals Latest Developments

13.5 Melinta Therapeutics

13.5.1 Melinta Therapeutics Company Information

13.5.2 Melinta Therapeutics Antibiotic Resistance Product Offered

13.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Melinta Therapeutics Main Business Overview

13.5.5 Melinta Therapeutics Latest Developments

13.6 Merck

13.6.1 Merck Company Information

13.6.2 Merck Antibiotic Resistance Product Offered

13.6.3 Merck Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Merck Main Business Overview

13.6.5 Merck Latest Developments

13.7 Nabriva Therapeutics

13.7.1 Nabriva Therapeutics Company Information

13.7.2 Nabriva Therapeutics Antibiotic Resistance Product Offered

13.7.3 Nabriva Therapeutics Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Nabriva Therapeutics Main Business Overview

13.7.5 Nabriva Therapeutics Latest Developments

13.8 Nemesis Bioscience

13.8.1 Nemesis Bioscience Company Information

13.8.2 Nemesis Bioscience Antibiotic Resistance Product Offered

13.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Nemesis Bioscience Main Business Overview

13.8.5 Nemesis Bioscience Latest Developments

13.9 Phage Technologies S.A

13.9.1 Phage Technologies S.A Company Information

13.9.2 Phage Technologies S.A Antibiotic Resistance Product Offered

13.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Phage Technologies S.A Main Business Overview

13.9.5 Phage Technologies S.A Latest Developments

13.10 Tetraphase Pharmaceuticals

13.10.1 Tetraphase Pharmaceuticals Company Information

13.10.2 Tetraphase Pharmaceuticals Antibiotic Resistance Product Offered

13.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Tetraphase Pharmaceuticals Main Business Overview

13.10.5 Tetraphase Pharmaceuticals Latest Developments

13.11 The Medicines Company

13.11.1 The Medicines Company Company Information

13.11.2 The Medicines Company Antibiotic Resistance Product Offered

13.11.3 The Medicines Company Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 The Medicines Company Main Business Overview

13.11.5 The Medicines Company Latest Developments

13.12 TPfizer

13.12.1 TPfizer Company Information

13.12.2 TPfizer Antibiotic Resistance Product Offered

13.12.3 TPfizer Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 TPfizer Main Business Overview

13.12.5 TPfizer Latest Developments

13.13 Westway Health

13.13.1 Westway Health Company Information

13.13.2 Westway Health Antibiotic Resistance Product Offered

13.13.3 Westway Health Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Westway Health Main Business Overview

13.13.5 Westway Health Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Antibiotic Resistance Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Antibiotic Resistance Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Type I

Table 4. Major Players of Type I

Table 5. Global Antibiotic Resistance Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Antibiotic Resistance Sales Market Share by Type (2017-2022)

Table 7. Global Antibiotic Resistance Revenue by Type (2017-2022) & ($ million)

Table 8. Global Antibiotic Resistance Revenue Market Share by Type (2017-2022)

Table 9. Global Antibiotic Resistance Sale Price by Type (2017-2022) & (USD/Pcs)

Table 10. Global Antibiotic Resistance Sales by Application (2017-2022) & (K Pcs)

Table 11. Global Antibiotic Resistance Sales Market Share by Application (2017-2022)

Table 12. Global Antibiotic Resistance Revenue by Application (2017-2022)

Table 13. Global Antibiotic Resistance Revenue Market Share by Application (2017-2022)

Table 14. Global Antibiotic Resistance Sale Price by Application (2017-2022) & (USD/Pcs)

Table 15. Global Antibiotic Resistance Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Antibiotic Resistance Sales Market Share by Company (2020-2022)

Table 17. Global Antibiotic Resistance Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Antibiotic Resistance Revenue Market Share by Company (2020-2022)

Table 19. Global Antibiotic Resistance Sale Price by Company (2020-2022) & (USD/Pcs)

Table 20. Key Manufacturers Antibiotic Resistance Producing Area Distribution and Sales Area

Table 21. Players Antibiotic Resistance Products Offered

Table 22. Antibiotic Resistance Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Antibiotic Resistance Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Antibiotic Resistance Sales Market Share Geographic Region (2017-2022)

Table 27. Global Antibiotic Resistance Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Antibiotic Resistance Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Antibiotic Resistance Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Antibiotic Resistance Sales Market Share by Country/Region (2017-2022)

Table 31. Global Antibiotic Resistance Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Antibiotic Resistance Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Antibiotic Resistance Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Antibiotic Resistance Sales Market Share by Country (2017-2022)

Table 35. Americas Antibiotic Resistance Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Antibiotic Resistance Revenue Market Share by Country (2017-2022)

Table 37. Americas Antibiotic Resistance Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Antibiotic Resistance Sales Market Share by Type (2017-2022)

Table 39. Americas Antibiotic Resistance Sales by Application (2017-2022) & (K Pcs)

Table 40. Americas Antibiotic Resistance Sales Market Share by Application (2017-2022)

Table 41. APAC Antibiotic Resistance Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Antibiotic Resistance Sales Market Share by Region (2017-2022)

Table 43. APAC Antibiotic Resistance Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Antibiotic Resistance Revenue Market Share by Region (2017-2022)

Table 45. APAC Antibiotic Resistance Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Antibiotic Resistance Sales Market Share by Type (2017-2022)

Table 47. APAC Antibiotic Resistance Sales by Application (2017-2022) & (K Pcs)

Table 48. APAC Antibiotic Resistance Sales Market Share by Application (2017-2022)

Table 49. Europe Antibiotic Resistance Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Antibiotic Resistance Sales Market Share by Country (2017-2022)

Table 51. Europe Antibiotic Resistance Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Antibiotic Resistance Revenue Market Share by Country (2017-2022)

Table 53. Europe Antibiotic Resistance Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Antibiotic Resistance Sales Market Share by Type (2017-2022)

Table 55. Europe Antibiotic Resistance Sales by Application (2017-2022) & (K Pcs)

Table 56. Europe Antibiotic Resistance Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Antibiotic Resistance Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Antibiotic Resistance Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Antibiotic Resistance Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Antibiotic Resistance Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Antibiotic Resistance Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Antibiotic Resistance Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Antibiotic Resistance Sales by Application (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Antibiotic Resistance Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Antibiotic Resistance

Table 66. Key Market Challenges & Risks of Antibiotic Resistance

Table 67. Key Industry Trends of Antibiotic Resistance

Table 68. Antibiotic Resistance Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Antibiotic Resistance Distributors List

Table 71. Antibiotic Resistance Customer List

Table 72. Global Antibiotic Resistance Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Antibiotic Resistance Sales Market Forecast by Region

Table 74. Global Antibiotic Resistance Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Antibiotic Resistance Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Antibiotic Resistance Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Antibiotic Resistance Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Antibiotic Resistance Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Antibiotic Resistance Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Antibiotic Resistance Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Antibiotic Resistance Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Antibiotic Resistance Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Antibiotic Resistance Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Antibiotic Resistance Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Antibiotic Resistance Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Antibiotic Resistance Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Antibiotic Resistance Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Antibiotic Resistance Sales Forecast by Application (2023-2028) & (K Pcs)

Table 89. Global Antibiotic Resistance Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Antibiotic Resistance Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Antibiotic Resistance Revenue Market Share Forecast by Application (2023-2028)

Table 92. Allergan Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors

Table 93. Allergan Antibiotic Resistance Product Offered

Table 94. Allergan Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 95. Allergan Main Business

Table 96. Allergan Latest Developments

Table 97. AmpliPhi Biosciences Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors

Table 98. AmpliPhi Biosciences Antibiotic Resistance Product Offered

Table 99. AmpliPhi Biosciences Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. AmpliPhi Biosciences Main Business

Table 101. AmpliPhi Biosciences Latest Developments

Table 102. BioVersys GmbH Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors

Table 103. BioVersys GmbH Antibiotic Resistance Product Offered

Table 104. BioVersys GmbH Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 105. BioVersys GmbH Main Business

Table 106. BioVersys GmbH Latest Developments

Table 107. Macrolide Pharmaceuticals Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors

Table 108. Macrolide Pharmaceuticals Antibiotic Resistance Product Offered

Table 109. Macrolide Pharmaceuticals Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 110. Macrolide Pharmaceuticals Main Business

Table 111. Macrolide Pharmaceuticals Latest Developments

Table 112. Melinta Therapeutics Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors

Table 113. Melinta Therapeutics Antibiotic Resistance Product Offered

Table 114. Melinta Therapeutics Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 115. Melinta Therapeutics Main Business

Table 116. Melinta Therapeutics Latest Developments

Table 117. Merck Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors

Table 118. Merck Antibiotic Resistance Product Offered

Table 119. Merck Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 120. Merck Main Business

Table 121. Merck Latest Developments

Table 122. Nabriva Therapeutics Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors

Table 123. Nabriva Therapeutics Antibiotic Resistance Product Offered

Table 124. Nabriva Therapeutics Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 125. Nabriva Therapeutics Main Business

Table 126. Nabriva Therapeutics Latest Developments

Table 127. Nemesis Bioscience Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors

Table 128. Nemesis Bioscience Antibiotic Resistance Product Offered

Table 129. Nemesis Bioscience Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 130. Nemesis Bioscience Main Business

Table 131. Nemesis Bioscience Latest Developments

Table 132. Phage Technologies S.A Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors

Table 133. Phage Technologies S.A Antibiotic Resistance Product Offered

Table 134. Phage Technologies S.A Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 135. Phage Technologies S.A Main Business

Table 136. Phage Technologies S.A Latest Developments

Table 137. Tetraphase Pharmaceuticals Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors

Table 138. Tetraphase Pharmaceuticals Antibiotic Resistance Product Offered

Table 139. Tetraphase Pharmaceuticals Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 140. Tetraphase Pharmaceuticals Main Business

Table 141. Tetraphase Pharmaceuticals Latest Developments

Table 142. The Medicines Company Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors

Table 143. The Medicines Company Antibiotic Resistance Product Offered

Table 144. The Medicines Company Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 145. The Medicines Company Main Business

Table 146. The Medicines Company Latest Developments

Table 147. TPfizer Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors

Table 148. TPfizer Antibiotic Resistance Product Offered

Table 149. TPfizer Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 150. TPfizer Main Business

Table 151. TPfizer Latest Developments

Table 152. Westway Health Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors

Table 153. Westway Health Antibiotic Resistance Product Offered

Table 154. Westway Health Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 155. Westway Health Main Business

Table 156. Westway Health Latest Developments

List of Figures

Figure 1. Picture of Antibiotic Resistance

Figure 2. Antibiotic Resistance Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Antibiotic Resistance Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Antibiotic Resistance Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Antibiotic Resistance Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Type I

Figure 10. Product Picture of Type I

Figure 11. Global Antibiotic Resistance Sales Market Share by Type in 2021

Figure 12. Global Antibiotic Resistance Revenue Market Share by Type (2017-2022)

Figure 13. Antibiotic Resistance Consumed in Oxazolidinones

Figure 14. Global Antibiotic Resistance Market: Oxazolidinones (2017-2022) & (K Pcs)

Figure 15. Antibiotic Resistance Consumed in Lipoglycopeptides

Figure 16. Global Antibiotic Resistance Market: Lipoglycopeptides (2017-2022) & (K Pcs)

Figure 17. Antibiotic Resistance Consumed in Tetracyclines

Figure 18. Global Antibiotic Resistance Market: Tetracyclines (2017-2022) & (K Pcs)

Figure 19. Antibiotic Resistance Consumed in Cephalosporins

Figure 20. Global Antibiotic Resistance Market: Cephalosporins (2017-2022) & (K Pcs)

Figure 21. Antibiotic Resistance Consumed in Combination therapies

Figure 22. Global Antibiotic Resistance Market: Combination therapies (2017-2022) & (K Pcs)

Figure 23. Antibiotic Resistance Consumed in Other

Figure 24. Global Antibiotic Resistance Market: Other (2017-2022) & (K Pcs)

Figure 25. Global Antibiotic Resistance Sales Market Share by Application (2017-2022)

Figure 26. Global Antibiotic Resistance Revenue Market Share by Application in 2021

Figure 27. Antibiotic Resistance Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Antibiotic Resistance Revenue Market Share by Company in 2021

Figure 29. Global Antibiotic Resistance Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Antibiotic Resistance Revenue Market Share by Geographic Region in 2021

Figure 31. Global Antibiotic Resistance Sales Market Share by Region (2017-2022)

Figure 32. Global Antibiotic Resistance Revenue Market Share by Country/Region in 2021

Figure 33. Americas Antibiotic Resistance Sales 2017-2022 (K Pcs)

Figure 34. Americas Antibiotic Resistance Revenue 2017-2022 ($ Millions)

Figure 35. APAC Antibiotic Resistance Sales 2017-2022 (K Pcs)

Figure 36. APAC Antibiotic Resistance Revenue 2017-2022 ($ Millions)

Figure 37. Europe Antibiotic Resistance Sales 2017-2022 (K Pcs)

Figure 38. Europe Antibiotic Resistance Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Antibiotic Resistance Sales 2017-2022 (K Pcs)

Figure 40. Middle East & Africa Antibiotic Resistance Revenue 2017-2022 ($ Millions)

Figure 41. Americas Antibiotic Resistance Sales Market Share by Country in 2021

Figure 42. Americas Antibiotic Resistance Revenue Market Share by Country in 2021

Figure 43. United States Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Antibiotic Resistance Sales Market Share by Region in 2021

Figure 48. APAC Antibiotic Resistance Revenue Market Share by Regions in 2021

Figure 49. China Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Antibiotic Resistance Sales Market Share by Country in 2021

Figure 56. Europe Antibiotic Resistance Revenue Market Share by Country in 2021

Figure 57. Germany Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Antibiotic Resistance Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Antibiotic Resistance Revenue Market Share by Country in 2021

Figure 64. Egypt Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Antibiotic Resistance in 2021

Figure 70. Manufacturing Process Analysis of Antibiotic Resistance

Figure 71. Industry Chain Structure of Antibiotic Resistance

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390